Skip to main content
. 2022 Mar 8;135(6):697–706. doi: 10.1097/CM9.0000000000002056

Figure 4.

Figure 4

The ROC curves of the 5-year recurrence risk models for the training set and test set for low-positive HER2 expression breast cancer. (A) ROC curve of the recurrence risk model, training set. (B) ROC curve of the recurrence risk model, test set. HER2: Human epidermal growth factor receptor 2; ROC: Receiving operator characteristic.